Drug Database
Back to search

Poland· PL-100205443

Preductal MR

A trimetazidine product containing trimetazidini dihydrochloridum, registered in Poland by Anpharm Przedsiębiorstwo Farmaceutyczne S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC C01EB15

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPreductal MRATCC01EB15REGISTER NO.PL-100205443PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trimetazidini dihydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trimetazidine is registered in 8 of 19 countries.

Countries holding a registration under ATC C01EB15 (trimetazidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search trimetazidine products by name

Trimetazidine · ATC C01EB15

8 / 19 countries

  • Czechiaprice
  • Denmark
  • Franceprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trimetazidine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Trimetazidine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Trimetazidini dihydrochloridum
Manufacturer
Anpharm Przedsiębiorstwo Farmaceutyczne S.A.
Country
Poland (PL)
ATC code
C01EB15
ATC class
Trimetazidine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

2 priced
  • gtin
    05909990846115
    60 szt.
    PLN 36.65
  • gtin
    05909991210083
    120 szt.
    PLN 70.54
  • gtin
    05909990846122

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trimetazidine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trimetazidine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Vastarel
  • Bulgaria · Модуксин Mr, Предуктал
  • Cyprus · Vastarel
  • Czechia · Preductal Mr, Protevasc
  • Denmark · Vastarel
  • Estonia · Preductal, Trimetazidine Servier
  • Spain · Idaptan, Trimetazidina Cinfa
  • France · Trimetazidine Biogaran, Trimetazidine Eg
  • Greece · Vastarel, Zidin
  • Croatia · Preductal Mr, Trimetazidin Pharmas
  • Hungary · Adexor Mr, Adexor Prolong
  • Ireland · Vastarel
  • Italy · Vastarel
  • Lithuania · Preductal, Trimetazidine Ingen Pharma
  • Luxembourg · Vastarel
  • Latvia · Preductal, Trimetazidine Mr Servier
  • Malta · Vastarel
  • Portugal · Trimetazidina Bluepharma, Trimetazidina Farmoz
  • Romania · Moduxin Mr, Preductal
  • Slovenia · Preductal Mr
  • Slovakia · Preductal, Protevasc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7303595-c906-4587-bb4b-135d63276b86
GET /v1/drugs/c7303595-c906-4587-bb4b-135d63276b86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o zmodyfikowanym uwalnianiu",
  "source": "urpl",
  "strength": "35 mg",
  "packaging": "05909990846115 ¦ Rp ¦ 16892\n60 tabl.\n05909990846122 ¦ Rp ¦ 20338\n90 tabl.\n05909991210083 ¦ Rp ¦ 106900\n120 tabl.",
  "substance": "Trimetazidini dihydrochloridum 35 mg",
  "common_name": "Trimetazidini dihydrochloridum",
  "pl_product_id": "100205443",
  "pozwolenie_nr": "08461",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about trimetazidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console